As of Aug 24
| -0.10 / -0.10%|
The 23 analysts offering 12-month price forecasts for CVS Caremark have a median target of 112.00, with a high estimate of 123.00 and a low estimate of 104.00. The median estimate represents a +15.26% increase from the last price of 97.17.
The current consensus among 25 polled investment analysts is to Buy stock in CVS Caremark. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.